Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration

NCT03699618 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03699618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03699618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration
Lead sponsor
Johns Hopkins University
Phase
Observational
Overall status
Terminated
Start date
May 29, 2019
Completion date
January 6, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration, submacular hemorrhage, wet macular degeneration